JUCTCi012-A

Registration Summary:

A P E C

The cell line is not submitted yet.

(only basic data is shown)

General

iPSC Line
hPSCreg name	JUCTCi012-A
Cite as:	JUCTCi012-A (RRID:CVCL_A9XI)
iPSC line type	Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines	No similar lines found.
Last update	14th January 2026
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	the University of Jordan / Cell Therapy center (JUCTC) Contact: the University of Jordan / Cell Therapy center (JUCTC)
Owner	the University of Jordan / Cell Therapy center (JUCTC)
Distributors	the University of Jordan / Cell Therapy center (JUCTC)
External iPSC Databases
Cellosaurus	CVCL_A9XI
Wikidata	Q102114333
BioSamples	SAMEA120918805
General iPSC Information
Publications	Ababneh NA et al. Establishment of a human induced pluripotent stem cell line, JUCTCi012-A, from multiple symmetric lipomatosis (MSL) patient carrying a homozygous Arg707Trp (c.2119C > T) mutation in the MFN2 gene. Stem cell research. 2020 Oct;48:101967. McKnight CL et al. Modelling Mitochondrial Disease in Human Pluripotent Stem Cells: What Have We Learned?. International journal of molecular sciences. 2021 Jul 20;22(14). Xiao W et al. LOX(G473A) induces the formation of osteoclasts in RAW264.7 cells via IL-6/JAK2/STAT3 signaling. Experimental cell research. 2021 Dec 1;409(1):112890. Hu B et al. Research progress on the pathogenesis of multiple symmetrical lipomatosis. Adipocyte. 2024 Dec;13(1):2416681.
* Is the cell line readily obtainable for third parties?	Yes Research use: allowed Clinical use: not allowed Commercial use: allowed

iPSC Derivation

General